Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 1, 1986
Pharmacokinetics and metabolism of [14C]rosaramicin in dogs
C C Lin, H K Kim, A Marco, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1973
SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent
C A Korduba, J Veals, A Wohl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1984
Isolation and identification of a metabolite of rosaramicin in human urine
C Lin, M S Puar, D Schuessler, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1984
Quazepam kinetics in the elderly
J M Hilbert, M Chung, E Radwanski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1985
Disposition and metabolic fate of 14C-quazepam in man
N Zampaglione, J M Hilbert, J Ning, et al.
Journal of Clinical Pharmacology
|
March 1, 1988
Excretion of loratadine in human breast milk
J Hilbert, E Radwanski, M B Affrime, et al.
Life Sciences
|
July 14, 1986
Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice
J M Hilbert, L Iorio, V Moritzen, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1984
Effect of sleep on quazepam kinetics
J M Hilbert, M Chung, G Maier, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1982
Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs
M Chung, L Parravicini, B M Assael, et al.
Journal of Clinical Pharmacology
|
April 1, 1986
Rising multiple-dose pharmacokinetics of labetalol in hypertensive patients
M Chung, F H Leitz, G Maier, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Antimicrobial Agents and Chemotherapy
|
May 1, 1986
Pharmacokinetics and metabolism of [14C]rosaramicin in dogs
C C Lin, H K Kim, A Marco, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1973
SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent
C A Korduba, J Veals, A Wohl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1984
Isolation and identification of a metabolite of rosaramicin in human urine
C Lin, M S Puar, D Schuessler, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1984
Quazepam kinetics in the elderly
J M Hilbert, M Chung, E Radwanski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1985
Disposition and metabolic fate of 14C-quazepam in man
N Zampaglione, J M Hilbert, J Ning, et al.
Journal of Clinical Pharmacology
|
March 1, 1988
Excretion of loratadine in human breast milk
J Hilbert, E Radwanski, M B Affrime, et al.
Life Sciences
|
July 14, 1986
Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice
J M Hilbert, L Iorio, V Moritzen, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1984
Effect of sleep on quazepam kinetics
J M Hilbert, M Chung, G Maier, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1982
Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs
M Chung, L Parravicini, B M Assael, et al.
Journal of Clinical Pharmacology
|
April 1, 1986
Rising multiple-dose pharmacokinetics of labetalol in hypertensive patients
M Chung, F H Leitz, G Maier, et al.
Page
of 7